The Asia-Pacific Mitral & Tricuspid Valve-in-Valve/Valve-in-Ring Registry (AP ViV Registry)

NCT07058935 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2025-07-10

No results posted yet for this study

Summary

A retrospective and prospective, observational, multicenter cohort study of consecutive patients undergoing transcatheter mitral/tricuspid ViV or ViR procedure with balloon expandable valve across participating sites in Asia-Pacific.

Conditions

  • Valve Disease, Heart

Sponsors & Collaborators

  • Edwards Lifesciences

    collaborator INDUSTRY
  • National Heart Centre Singapore

    lead OTHER

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-03-17
Primary Completion
2035-12-31
Completion
2035-12-31

Countries

  • Australia
  • Hong Kong
  • India
  • New Zealand
  • Singapore
  • Thailand

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07058935 on ClinicalTrials.gov